Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-43

Now we've got the best person we could possibly hope for for the job getting E4 off the ground Dr Myers a US Citizen familiar with how things are done there , highly qualified , wealth of experience in the pharma industry plus playing a major role in the actual development of the product being marketed and seems to have a real belief in it . Who knows whether this product a success or not but surely we've got considerably more chance now than we had before now we have somebody from Mithra on Mayne's board that knows what they're doing ( at long last ) to help get E4 off the ground . Don't believe generic NUVARING approval delay is the real reason behind depressed share price , not sure there's a lot in it now competitors ahead of us , product discounting etc. Market knows that .